Evoke Wealth’s Dr. Reddy's Laboratories RDY Stock Holding History

Evoke Wealth’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-300	Closed	-$3K	–	959
2022 Q3	$3K	Hold	300	–	–	﹤0.01%	986
2022 Q2	$3K	Hold	300	–	–	﹤0.01%	1005
2022 Q1	$3K	Hold	300	–	–	﹤0.01%	1010
2021 Q4	$4K	Hold	300	–	–	﹤0.01%	955
2021 Q3	$3K	Hold	300	–	–	﹤0.01%	960
2021 Q2	$4K	Hold	300	–	–	﹤0.01%	943
2021 Q1	$4K	Hold	300	–	–	﹤0.01%	901
2020 Q4	$4K	Hold	300	–	–	﹤0.01%	780
2020 Q3	$4K	Hold	300	–	–	﹤0.01%	726
2020 Q2	$3K	Hold	300	–	–	﹤0.01%	810
2020 Q1	$2.42K	Hold	300	–	–	﹤0.01%	769
2019 Q4	$2.44K	Hold	300	–	–	﹤0.01%	1042
2019 Q3	$2.27K	Buy	+300	New	+$2.23K	﹤0.01%	1180

Other funds holding RDY

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

Evoke Wealth's RDY Position: Q4 2022 in Review

Evoke Wealth sold out of Dr. Reddy's Laboratories (RDY) in Q4 2022, closing a stake of 300 shares — an estimated $3K sold.

Evoke Wealth first reported a position in RDY in Q3 2019 and held it in 13 quarters. The position peaked at $4K in Q4 2021. 161 funds tracked by Wall St. Rank hold RDY as of Q4 2022.

Evoke Wealth reported no remaining Dr. Reddy's Laboratories position as of Q4 2022 after selling out during the quarter.
Evoke Wealth sold 300 Dr. Reddy's Laboratories shares in Q4 2022, an estimated $3K.
Evoke Wealth first reported a position in Dr. Reddy's Laboratories in Q3 2019 and held it in 13 quarters.
Evoke Wealth's Dr. Reddy's Laboratories position peaked at $4K in Q4 2021.
161 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q4 2022.

Based on Evoke Wealth's 13F filing for Q4 2022, filed 10 Feb 2023.